AstraZeneca Sales, Profit Outshine Estimates on Cancer Drugs
AstraZeneca Plc reported better-than-expected profit and revenue in the fourth quarter and forecast further gains, helped by ...
AstraZeneca faces potential fines in China over unpaid import taxes
AstraZeneca said the taxes related to two cancer drugs, Imfinzi and Imjudo, and that it was continuing to co-operate with ...
Drugmaker AstraZeneca flags possible $4.5 million Chinese tax fine
AstraZeneca could face a fine of up to $4.5 million in China over suspected unpaid taxes related to the import of two of its ...
AstraZeneca faces potential fines in China over import taxes
AstraZeneca said authorities in Shenzhen have said the unpaid taxes amount to 0.9 million dollars (£0.7 million) and that it ...
manilatimes4h
Anti-HER2 Bispecific ADC JSKN003 Received Approval to Initiate a Phase III Clinical Study for the Treatment of HER2-positive Breast Cancer
Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ('CSPC') (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has ...
WINK NEWS7h
Gene therapy shows promise for bladder cancer patients
The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with nearly 17,000 ...
News Medical7h
Inhibiting S6K2 gene offers potential treatment for drug-resistant melanoma
The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .
‘With a cancer day care centre in my district, I can save on treatment and travel costs, save my mother’
As the cancer day care centre at AIIMS, Delhi, spills over, families hope decentralised treatment will cut costs, minimise ...
Terminally ill patient is 'cured' of immune illness after AI identifies drug for 'repurposing'
The patient has iMCD, which has a poor survival rate and few treatment options but an AI tool searched through 4,000 ...
Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
Light-activated compound offers hope for overcoming drug resistance in cancer treatment
A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using ...
Mutations in two gene pairs point to a promising drug target in 5% of adult cancers
Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have ...